ZAQS.ORG

August was the month of the comeback kids. Cramer reviews what drove the biggest winners

16 hours ago

Trump strikes new drug pricing deals with nine midsized drugmakers

20 hours ago

BioCryst is profitable. Now it wants to buy more rare disease drugs

4 days ago

How Taylor Farms became integral to America's food supply system

4 days ago

FDA approves daily HIV pill from Gilead designed to simplify treatment

4 days ago

HHS plans new FDA leadership roles for technology and drugs, sources say

4 days ago

Why vaccination rates are falling in the U.S.

6 days ago

BioMarin to acquire Alesta Therapeutics for $275 million

11 days ago

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

12 days ago

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

14 days ago

The startup using AI to help rare disease families develop custom treatments

14 days ago

Court rules companies can't import Gilead medications from overseas

14 days ago

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

19 days ago

Trump administration ends Medicaid, CHIP funding for gender-affirming care for children

20 days ago

We're lifting our price target on Cardinal Health after issuing rosy profit guidance

20 days ago

Trump wants to split the MMR vaccine. Experts say that's unlikely

20 days ago

Jazz Pharmaceuticals to buy Actio Biosciences for $820 million

20 days ago

Eli Lilly takes weight-loss pill battle global

21 days ago

Trump signs order calling for fewer childhood vaccines, falsely linking shots to autism

21 days ago

New genetic tests are catching rare diseases before symptoms start

21 days ago

Why we like Boeing's latest deal — plus, what to expect from this health stock

21 days ago

Hunter Biden says Joe Biden's cancer has spread further, 'very painful'

21 days ago

Cyclospora fears lead consumers to lose their appetite for salads

24 days ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

25 days ago

Sen. Mitch McConnell says he's left rehab, will work from home

25 days ago

CAMP4 advances rare disease treatment for SYNGAP1 into human trials

25 days ago

Divide between Eli Lilly and Novo Nordisk is widening after latest earnings

25 days ago

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

26 days ago

This stock is more than a way to play GLP-1 boom

26 days ago

Bank of America spends $250M a year on GLP-1 drugs for its employees, CEO says

26 days ago

Eli Lilly blows past estimates, raises outlook on Zepbound and Mounjaro sales

27 days ago

CVS blows past estimates, hikes guidance as insurance unit continues to improve

27 days ago